Is Glyphosate Safe? A Plain-Language Guide for Consumers
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Category Archives: Newsroom
The weaponization of Editorship and complicity of corporate publishers in eroding scientific integrity
You are unauthorized to view this page.
Beyond Science and Decisions XIV PFAS Limits How Did We Get So Far Apart – Workshop Paper Compilation
You are unauthorized to view this page.
ISRTP Joins Amicus Curiae Brief in Monsanto Company v. Durnell
Compilation of PFAS Papers on “Safe Dose” Determinations
You are unauthorized to view this page.
Workshop XV: Beyond Science and Decisions—From Problem Formulation to Comprehensive Risk Assessment
You are unauthorized to view this page.
FDA announced a concrete roadmap to reduce, refine, or replace animal testing requirements using New Approach Methodologies (NAMs)
BRIEF OF PAUSTENBACH & ASSOCIATES et al. AS AMICUS CURIAE IN SUPPORT OF PETITIONERS
P&A PFAS Amicus Brief Filed 04.18.2025
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
https://www.fda.gov/news-events/press-announcements/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs#:~:text=FDA%20Announces%20Plan%20to%20Phase,Antibodies%20and%20Other%20Drugs%20%7C%20FDA For Immediate Release: April 10, 2025 Today, the U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development […]
BRIEF OF AMICI CURIAE TOXICOLOGY EXCELLENCE FOR RISK ASSESSMENT AND THE INTERNATIONAL SOCIETY FOR REGULATORY TOXICOLOGY AND PHARMACOLOGY IN SUPPORT OF PETITIONERS AND VACATUR
Click here to download document: 2025-04-15 FILED TERA ISRTP Brief[48]